79 related articles for article (PubMed ID: 26399531)
1. Transcriptome screening and verification of genes related to metabolism affected by histone deacetylase inhibitors.
Cao JH; Liao WT; Wo C; Xu GR; Xu HX; Li P; Tao Y; Wang P; Lin JR; Deng LR
Yi Chuan; 2015 Sep; 37(9):918-25. PubMed ID: 26399531
[TBL] [Abstract][Full Text] [Related]
2. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
Mazzio EA; Soliman KF
Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
[TBL] [Abstract][Full Text] [Related]
3. Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells.
Majumdar G; Adris P; Bhargava N; Chen H; Raghow R
BMC Genomics; 2012 Dec; 13():709. PubMed ID: 23249388
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation.
Feng Q; Su Z; Song S; Χu H; Zhang B; Yi L; Tian M; Wang H
Int J Mol Med; 2016 Sep; 38(3):812-22. PubMed ID: 27460781
[TBL] [Abstract][Full Text] [Related]
5. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
6. The effect of histone deacetylase inhibitor trichostatin A on porcine mesenchymal stem cell transcriptome.
Gurgul A; Opiela J; Pawlina K; Szmatoła T; Bochenek M; Bugno-Poniewierska M
Biochimie; 2017 Aug; 139():56-73. PubMed ID: 28552396
[TBL] [Abstract][Full Text] [Related]
7. Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells.
Di Bernardo G; Alessio N; Dell'Aversana C; Casale F; Teti D; Cipollaro M; Altucci L; Galderisi U
J Cell Physiol; 2010 Nov; 225(2):537-44. PubMed ID: 20458754
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Li QQ; Hao JJ; Zhang Z; Hsu I; Liu Y; Tao Z; Lewi K; Metwalli AR; Agarwal PK
Int J Oncol; 2016 Jun; 48(6):2591-607. PubMed ID: 27082124
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X
PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
Xie R; Yao Y; Tang P; Chen G; Liu X; Yun F; Cheng C; Wu X; Yuan Q
Eur J Med Chem; 2017 Jul; 134():1-12. PubMed ID: 28391133
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
13. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA).
Agudelo M; Gandhi N; Saiyed Z; Pichili V; Thangavel S; Khatavkar P; Yndart-Arias A; Nair M
Alcohol Clin Exp Res; 2011 Aug; 35(8):1550-6. PubMed ID: 21447001
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells.
Huynh NC; Everts V; Pavasant P; Ampornaramveth RS
J Cell Biochem; 2016 Jun; 117(6):1384-95. PubMed ID: 27043246
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
Duncan HF; Smith AJ; Fleming GJ; Cooper PR
J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
[TBL] [Abstract][Full Text] [Related]
16. High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line.
Yamato E
Endocr Regul; 2018 Jan; 52(1):21-26. PubMed ID: 29453918
[TBL] [Abstract][Full Text] [Related]
17. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
Asgar MA; Senawong G; Sripa B; Senawong T
Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
[TBL] [Abstract][Full Text] [Related]
19. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
20. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
